Stefanie Johns
CIK 1823147 · View on SEC EDGAR ↗
First SEC filing: Feb. 1, 2021 · Latest: Feb. 1, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 16, 2022 | RKTO | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 29, 2021 | RKTO | A | 125,000 | — | — | 125,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 16, 2022 | RKTO | Options | Common Stock (250,000) | $0.59 | March 16, 2032 | 250,000 | Acquired |
| Jan. 29, 2021 | RKTO | Options | Common Stock (125,000) | $2.11 | Jan. 29, 2031 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RKTO
Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $382,443 | $20,000 | — | $108,181 | — | — | $185,263 | $695,886 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.